Prolor Biotech, Inc.
SEC CIK 1268659 · PBTH · last insider filing 2013-09-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hsiao Jane PH D | Director | filed 2007 - 2013 |
| Frost Gamma Investments Trust | Director | filed 2007 - 2013 |
| Rubin Steven D | Director | filed 2008 - 2013 |
| Novik Shai A | Director · President | filed 2007 - 2013 |
| Fares Fuad | Director | filed 2007 - 2013 |
| Havron Abraham | Director · Chief Executive Officer | filed 2007 - 2013 |
| Stern Adam K | Director | filed 2007 - 2013 |
| Gorecki Marian | Director | filed 2008 - 2013 |
| Frost Phillip MD ET AL | Director | filed 2007 - 2013 |
| Kanter Joel S | Director | filed 2007 - 2008 |
| Bauer Eugene A | Director | filed 2007 - 2008 |
| Clemow Alastair J T | Director | filed 2007 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schaeffer Steve | Chief Financial Officer | filed 2010 - 2010 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.